Underweight BMI Independently Predicts Inferior Survival in DLBCL Treated With R-CHOP: A Lymphoma Registry Study.
OBJECTIVES BMI may capture clinically relevant differences in host reserve and treatment vulnerability in diffuse large B-cell lymphoma (DLBCL). We evaluated the association between BMI and survival outcomes. METHODS Adults with DLBCL receiving first-line R-CHOP chemoimmunotherapy from 2016 to 2026 were identified fr...